Latest Douglas A. Melton Stories
BOSTON, Sept. 1 /PRNewswire/ -- Stemgent, Inc. announced today that it has pledged a financial gift to the Harvard Stem Cell Institute (HSCI) Seminar Series Fund in support of the HSCI 2009 - 2010 Seminar Series.
SOUTH SAN FRANCISCO, Calif., Aug. 6 /PRNewswire/ -- iPierian, Inc., a biopharmaceutical company focused on changing the paradigm of drug discovery and development through the application of cellular reprogramming, today announced the appointments of Dr. Chad Cowan and Dr.
For years researchers have been searching for a way to treat diabetics by reactivating their insulin-producing beta cells, to no avail. Now, they may be one step closer.
SOUTH SAN FRANCISCO, Calif. and BOSTON, July 8 /PRNewswire/ -- iZumi Bio, Inc. and Pierian, Inc. today announced they have merged to form a new company, iPierian, Inc.
- National Poll Reveals Three-Quarters of Americans Want President-Elect Obama to Deliver on Campaign Commitment to Lift Restrictions on Embryonic Stem Cell Research - WASHINGTON, Jan.
The successful creation of the first induced pluripotent stem (iPS) cell line from adult monkey skin may have important implications for direct reprogramming capabilities across different species.
Researchers said on Sunday they found a shortcut to transforming ordinary skin cells into powerful stem cells by "sprinkling" a chemical onto the cells.
By Malcolm Ritter NEW YORK - Talk about an extreme makeover: Scientists have transformed one type of cell into another in living mice, a big step toward the goal of growing replacement tissues to treat a variety of diseases.
By The Associated Press NEW YORK (AP) - Talk about an extreme makeover: Scientists have transformed one type of cell into another in living mice, a big step toward the goal of growing replacement tissues to treat a variety of diseases.The cell identity switch turned ordinary pancreas cells into the rarer type that churns out insulin, essential for preventing diabetes.
The California Institute for Regenerative Medicine (CIRM), the state stem cell agency, issued the following statement regarding the research published today in Nature by a team from Harvard that showed it is possible to take a type of adult pancreas cell that doesn't normally produce insulin and reprogram them to produce insulin.
- totally perplexed and mixed up.